These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3118589)

  • 1. [Interactions of non-steroidal antirheumatic drugs with oral antidiabetic agents: acemetacin--glibenclamide].
    Haupt E; Hoppe FK; Rechziegler H; Zündorf P
    Z Rheumatol; 1987; 46(4):170-3. PubMed ID: 3118589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, controlled parallel group study evaluating the efficacy and safety of acemetacin for the management of osteoarthritis.
    Chou CT; Tsai YY
    Int J Clin Pharmacol Res; 2002; 22(1):1-6. PubMed ID: 12395912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of acemetacin and indometacin on gastrointestinal blood loss in normal volunteers and rheumatic patients (author's transl)].
    Uthgenannt H; Mohing W; Köhler G; Schmidt F; Havemann R
    Arzneimittelforschung; 1980; 30(8A):1424-7. PubMed ID: 6968220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.
    Vray M; Attali JR
    Diabete Metab; 1995 Dec; 21(6):433-9. PubMed ID: 8593925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mofebutazone--evaluation of possible interaction with glibenclamide].
    Speders S
    Fortschr Med; 1993 Aug; 111(22-23):366-8. PubMed ID: 8406274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a double-blind study with indomethacin and indoprofen, a new non-steroidal antirheumatic agent.
    Seigmund H; Schneider B
    Eur J Rheumatol Inflamm; 1981; 4(1):79-86. PubMed ID: 7042366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
    Kyllästinen M; Groop L
    Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interactions between diclofenac and glibenclamide].
    Chlud K
    Z Rheumatol; 1976; 35(9-10):377-82. PubMed ID: 824884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
    Mück W; Heine PR; Breuel HP; Niklaus H; Horkulak J; Ahr G
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):89-94. PubMed ID: 7757317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acemetacin and indomethacin in the treatment of rheumatoid arthritis: a double-blind comparative study in general practice.
    Saul PA; Korlipara K
    Curr Med Res Opin; 1991; 12(5):332-41. PubMed ID: 2004546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic polyarthritis with acemetacin and indomethacin].
    Badia-Flores J; Muñoz Barradas F
    Arzneimittelforschung; 1980; 30(8A):1433-7. PubMed ID: 7191311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind multicentre, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis patients under basic steroid treatment.
    del Campo JB
    Eur J Rheumatol Inflamm; 1981; 4(1):135-43. PubMed ID: 7042357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.
    Grandt R; Braun W; Schulz HU; Lührmann B; Frercks HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1451-4. PubMed ID: 2515864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of two glibenclamide preparations, HB 419 and HB 420, in maturity-onset (type 2) diabetic patients.
    Arnala I; Uusitupa M
    Ann Clin Res; 1983; 15 Suppl 37():33-5. PubMed ID: 6433770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled double blind comparison of acemetacin to indomethacin in patients with chronic polyarthritis].
    Heiter A; Tausch G; Eberl R
    Arzneimittelforschung; 1980; 30(8A):1427-33. PubMed ID: 7191310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
    Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
    J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.